← Open Payments lookup

KRISTEN GORDY: Open Payments

NPI 1811332307 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$487 in 29 payments from 10 companies in 2025. Trend: 2023 $274 · 2024 $437 · 2025 $487

Food & beverage: $487
CompanyPaymentsAmount
ABBVIE INC.12$161
E.R. Squibb & Sons, L.L.C.3$61
Takeda Pharmaceuticals U.S.A., Inc.3$54
Teva Pharmaceuticals USA, Inc.2$45
Axsome Therapeutics, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$32
Supernus Pharmaceuticals, Inc.2$31
Vanda Pharmaceuticals Inc.1$26
Lundbeck LLC1$22
Neurocrine BioSciences, Inc.1$14

Products named: VRAYLAR, COBENFY, REXULTI, TRINTELLIX, AUSTEDO XR, Auvelity, Qelbree, FANAPT.

Industry payments across MD — which companies pay providers there.